Study title: Efficacy and tolerability of Ipratropium bromide solution in the prevention of exercise-induced bronchospasm in children.
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Respiratory Tract Diseases [C08] | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: IPRATROPIUM | |||||
| ATC code: | |||||
| Document link: Ipratropium bromide_U92-0573_synopsis.pdf | |||||
| Document date: 2011-09-22 | |||||
| Study number: U92-0573 | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | - | |